Retrospective analysis finds treatment responses vary in acute myeloid leukemia with myelodysplasia-related changes, indicating the role of genetic factors.
Key Points
Overall survival did not differ significantly across induction regimens after adjusting for propensity score matching, highlighting treatment complexities.
Acute myeloid leukemia patients with epigenetic mutations responded well to various induction regimens, with unique response rates observed.
Complete remission rates varied markedly among treatments; notably, patients on HMA-Ven showed a 58% response rate, underlining varied treatment efficacy.
Allogeneic stem cell transplant improved relapse-free survival substantially, indicating its importance in the management of acute myeloid leukemia.